Saturday, 31 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 12, 2025

WENDEL : Journée Investisseurs de Wendel

View original at globenewswire.com
WENDEL : Journée Investisseurs de Wendel Transformation de Wendel : deux moteurs puissants de création de valeur devant générer plus de 7 milliards d’euros de trésorerie d’ici fin 2030 et retourner au moins 1,6 milliard aux actionnaires Annulation de 3,8% du capital auto-détenu et lancement d'un rachat d’actions représ…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Wendel will generate over 7 billion euros in cash flow by 2030 from recurring asset management fees and portfolio divestments, and allocate more than 1.6 billion euros in shareholder returns through dividends and share buybacks

    80% confidence
  • WIM will benefit over time from participation in fund performance (PRE), which can represent approximately 300 million euros for all upcoming fund vintages

    80% confidence
  • In 3 years, Wendel has become a global and unique investment company through its model dedicated to private assets with two complementary value-creating businesses: WPI for proprietary direct investment and WIM for third-party management

    80% confidence
  • By end of 2030, the asset management business should represent more than half of Wendel's intrinsic value

    80% confidence
  • WPI aims to generate average annual growth in intrinsic value of proprietary assets between 12% and 16%

    80% confidence
  • Annual dividend corresponds to (i) 2.5% of WPI's revalued net asset value and (ii) approximately 90% of dividends paid by WIM. Medium-term, WIM cash flow growth should allow dividend to reach approximately 3.5% of NAV

    80% confidence
  • WIM should manage over 46 billion in assets and exceed 200 million euros in pro forma FRE in 2026 across private equity, private debt and private markets solutions

    80% confidence
  • WIM targets average organic FRE growth of 15% per year through end of 2030

    80% confidence
  • Wendel is confident in its ability to achieve these ambitious objectives with talented teams, an optimized model offering synergy opportunities, good sector and geographic diversification, and solid financial capabilities

    80% confidence
  • WPI will progressively implement a direct investment program under the IK Partners advisory mandate, representing approximately 300 million euros per year per transaction, potentially including co-investors for an equivalent amount

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
WENDEL : Journée Investisseurs de Wendel — Source | Via News | ViaNews EU